Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
146.15%
↑ 8896% above average
Average (30q)
-1.66%
Historical baseline
Range
High:146.15%
Low:-248.48%
Volatility
-23751.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 146.15% |
| Q2 2025 | 35.00% |
| Q1 2025 | -124.22% |
| Q4 2024 | 72.97% |
| Q3 2024 | 21.43% |
| Q2 2024 | -31.25% |
| Q1 2024 | 55.56% |
| Q4 2023 | 1.37% |
| Q3 2023 | 37.07% |
| Q2 2023 | 10.77% |
| Q1 2023 | -4.84% |
| Q4 2022 | 36.08% |
| Q3 2022 | -44.78% |
| Q2 2022 | -2.29% |
| Q1 2022 | 7.75% |
| Q4 2021 | -24.56% |
| Q3 2021 | -35.71% |
| Q2 2021 | -10.53% |
| Q1 2021 | 3.80% |
| Q4 2020 | 21.78% |
| Q3 2020 | -7.45% |
| Q2 2020 | 18.26% |
| Q1 2020 | -248.48% |
| Q4 2019 | 17.50% |
| Q3 2019 | -81.82% |
| Q2 2019 | -22.22% |
| Q1 2019 | -20.00% |
| Q4 2018 | 28.57% |
| Q3 2018 | 92.58% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |